NATUERA AND BRC COMPLETE FIRST IMPORT OF CANNABIS-DERIVED THC FROM COLOMBIA INTO THE UNITED STATES
NATUERA AND BRC COMPLETE FIRST IMPORT OF CANNABIS-DERIVED THC FROM COLOMBIA INTO THE UNITED STATES This is the first export-import of high-THC cannabis derivative products from Colombia to the United States conducted in compliance with applicable laws. The shipment, sent from NatuEra’s fully licensed, GMP-designed facility, located outside of Bogotá, was imported under a DEA permit by BRC for R&D purposes. March 30, 2021 – NatuEra S.à.r.l. (“NatuEra”), a joint venture between Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”) and an affiliate of Agroidea, and Biopharmaceutical Research Company (“BRC”), are pleased to announce the first successful shipment of cannabis-derived high-THC extract from Colombia to the United States, in compliance with applicable laws. This shipment of THC will be used for scientific research and analysis related to cannabis composition and safety, aimed at informing the ongoing policy discussions surrounding the advancement of a responsible, science-based framework for federal cannabis…
NatuEra successfully completes first export to the United Kingdom
05 November 2020. During the month of August 2020, NatuEra’s wholly-owned subsidiary in Colombia successfully completed its first export to the United Kingdom of hemp-derived CBD distillate, manufactured at its state-of-the-art, cultivation and GMP-designed extraction facility, strategically located 25 miles from Bogotá. The shipment of hemp-derived CBD distillate, conducted under a non-controlled ruling issued by Colombia’s Narcotic Control Board, is to be used for R&D purposes as part of an ongoing study to collect toxicology data on CBD and gather safety information related to NatuEra’s novel foods application process. “At NatuEra we firmly believe that the world’s hemp and cannabis-derived cannabinoid industry must be built on the cornerstone of safety and compliance. That’s why we’re committed to ensuring that our ingredients and products are safe and stable, under the highest scientific standards. The UK is one of the first countries to have set out a clear regulatory pathway for the use of CBD ingredients in…
NatuEra granted R&D quotas to cultivate and manufacture psychoactive cannabis
05 November 2020. During the third quarter of 2020, NatuEra’s wholly-owned subsidiary in Colombia was awarded a total of four R&D quotas by the Colombian government to cultivate cannabis and manufacture cannabis-derived products at its fully-licensed state-of-the-art, vertically-integrated production facilities, strategically located 25 miles outside of Bogota. The permits issued by the Ministry of Health and Social Protection and the Ministry of Justice and Law include one cultivation quota to conduct field trials and characterize psychoactive cannabis cultivars, one cultivation quota to conduct R&D related to the manufacture of psychoactive cannabis derivatives, and two R&D manufacturing quotas to analyze and characterize cannabis-derived THC bulk products. “NatuEra is fully-licensed to cultivate and manufacture psychoactive cannabis products in Colombia and we’re delighted to have been granted these R&D quotas from the Colombian government, which will allow us to evaluate and register proprietary cannabis cultivars, as well as to compile valuable data for…
NatuEra successfully completes firsts exports to the United States.
March 2020. During the first and second quarters of 2020, NatuEra’s wholly-owned subsidiary in Colombia successfully completed its first exports to the United States of federally-compliant hemp-derived CBD distillate manufactured at its fully-licensed, state-of-the-art, GMP-designed cultivation and extraction facility, strategically located 25 miles from Bogota. These test exports were conducted for R&D and business development purposes under a Certificate of Non-Control issued by Colombia’s Narcotic Control Board. “The successful completion of four exports of CBD distillate to the United States over the past few months is a remarkable operational milestone for NatuEra. It speaks very highly of our team’s ability to produce and deliver CBD distillate bulk products in compliance with all applicable regulations and in conformance to world-class technical specifications. At NatuEra we know that this nascent industry is all about breaking down boundaries and it’s exciting to open up this new trade route to offer our hemp-derived bulk products in…